Authors: DENG C GOLUSZKO E DEDHIA V CHRISTADOSS P

Citation: C. Deng et al., FAS-MEDIATED APOPTOSIS IS ONE OF THE MECHANISMS OF HIGH-DOSE ACETYLCHOLINE-RECEPTOR T-CELL EPITOPE TOLERANCE IN EXPERIMENTAL MYASTHENIA-GRAVIS, The FASEB journal, 12(4), 1998, pp. 1809-1809

Authors: DEDHIA V GOLUSZKO E WU B DENG CS CHRISTADOSS P

Citation: V. Dedhia et al., THE EFFECT OF B-CELL DEFICIENCY ON THE IMMUNE-RESPONSE TO ACETYLCHOLINE-RECEPTOR AND THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 266-275

Authors: KAUL R WU B GOLUSZKO E DENG CS DEDHIA V NABOZNY GH DAVID CS RIMM IJ SHENOY M HAQQI TM CHRISTADOSS P

Citation: R. Kaul et al., EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN B10.BV8S2 TRANSGENIC MICE - PREFERENTIAL USAGE OF TCRAV1 GENE BY LYMPHOCYTES RESPONDING TO ACETYLCHOLINE-RECEPTOR, The Journal of immunology, 158(12), 1997, pp. 6006-6012

Authors: DENG C GOLUSZKO E WU B BARON S DEDHIA V CHRISTADOSS P

Citation: C. Deng et al., INTERFERON-ALPHA THERAPY FOR ESTABLISHED CLINICAL EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS INDUCES REMISSION, The FASEB journal, 10(6), 1996, pp. 152-152

Authors: DEDHIA V GOLUSZKO E CHRISTADOSS P

Citation: V. Dedhia et al., ROLE OF CD8-CELLS IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)( T), The FASEB journal, 10(6), 1996, pp. 1760-1760